Today’s stock pick update

Learn More Under the Radar Stocks Receive New Buy Signals Picking just one of these under-the-radar stocks at the best time is what has made wall street insiders filthy rich. Investors have been cashing in on double, triple and quadruple-digit returns of 1,930%, 617%, 2,062% and 1,633%. [ad] And finding them is easier than you think. Credit Suisse & Nomura Shares Drop On Warnings Of “Significant” Hits To Q1 Earnings From Archegos Fallout

Credit Suisse and Nomura are down 12% and 13%, respectively, this morning after warning of “significant” hits to first quarter results after they began exiting positions with Archegos Capital Management which defaulted on margin calls last week. “While at this time it is premature to quantify the exac... Read More

Century Aluminum (NASDAQ: CENX): Century Aluminum shares are up nearly 12% over the last week after announcing that it has finalized and received all necessary approvals for its new, three-year power contract with South Carolina Public Service Authority for the Mt. Holly aluminum smelter. “We are thrilled to have reached final agreement on this new contract which, most importantl... Read More

Is UFS a smart, small-cap bet in a reopening economy? In a broad sense, the market has been moving for most of the past year on the same basis – anticipating the end of the pandemic on the assumption that once the health crisis has passed, the economy can get back to churning along. The last week, however has raised concerns about inflation risks, which I think makes sense. Federal stimulus has kept pumping money into the economy, and the Fed has maintained its public stance that since it is willing to accept somewhat higher inflation leve... Read More

Your Featured Stock Vericel Corporation (VCEL) – Buy Price: $57.00 or better Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the t... Read More

Other Top Stories Biden boosts offshore wind energy, wants to power 10M homes Economist who pulled Albania out of 1997 anarchy dead at 58 Reacting to bloody coup, US suspends trade deal with Myanmar A key to bridging the political divide: Sit down and talk? UK agency: Vaccination rates lowest among older Black people

Trend Following Picks Vericel Corporation (VCEL) – Buy Price: $57.00 or better Bally’s Corporation (BALY) – Buy Price: $75.00 or better Live Oak Bancshares, Inc. (LOB) – Buy Price: $68.00 or better Annovis Bio, Inc. (ANVS) – Buy Price: $38.00 or better Wyndham Hotels & Resorts, Inc. (WH) – Buy Price: $71.00 or better All Picks

Reversal Picks Matinas BioPharma Holdings, Inc. (MTNB) Buy Target $1.38 Sell Target $1.70 Oragenics, Inc. (OGEN) Buy Target $1.10 Sell Target $1.37 Orla Mining Ltd. (ORLA) Buy Target $4.17 Sell Target $4.89 VolitionRx Limited (VNRX) Buy Target $4.64 Sell Target $5.41 Impac Mortgage Holdings, Inc. (IMH) Buy Target $2.76 Sell Target $3.29 All Picks

Low Price Stock Picks Charah Solutions, Inc. (CHRA) MicroSectors FANG+ Index -3X Inverse Leveraged ETN (FNGD) Global Tech Industries Group, Inc. (GTII) Weidai Ltd. (WEI) StoneMor Inc. (STON) All Picks

Already subscribed to our premium service? Click here to Login. Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

 

This email was sent to phanhoa1821960.trader@blogger.com  from Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037  Unsubscribe  Disclaimers, Terms & Conditions | Privacy Policy Copyright 2020  Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.